This statistic shows the share of therapy fields in the clinical and preclinical development pipeline in biotech companies in Germany as of 2013. That year, oncology comprised 56 percent of all therapy fields in clinical development in Germany.
Share of therapy fields in the clinical and preclinical development pipeline in biotech companies in Germany as of 2013
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
EY. (April 15, 2014). Share of therapy fields in the clinical and preclinical development pipeline in biotech companies in Germany as of 2013 [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/579973/development-pipeline-biotech-companies-germany-therapy-fields/
EY. "Share of therapy fields in the clinical and preclinical development pipeline in biotech companies in Germany as of 2013." Chart. April 15, 2014. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/579973/development-pipeline-biotech-companies-germany-therapy-fields/
EY. (2014). Share of therapy fields in the clinical and preclinical development pipeline in biotech companies in Germany as of 2013. Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/579973/development-pipeline-biotech-companies-germany-therapy-fields/
EY. "Share of Therapy Fields in The Clinical and Preclinical Development Pipeline in Biotech Companies in Germany as of 2013." Statista, Statista Inc., 15 Apr 2014, https://www.statista.com/statistics/579973/development-pipeline-biotech-companies-germany-therapy-fields/
EY, Share of therapy fields in the clinical and preclinical development pipeline in biotech companies in Germany as of 2013 Statista, https://www.statista.com/statistics/579973/development-pipeline-biotech-companies-germany-therapy-fields/ (last visited December 22, 2024)
Share of therapy fields in the clinical and preclinical development pipeline in biotech companies in Germany as of 2013 [Graph], EY, April 15, 2014. [Online]. Available: https://www.statista.com/statistics/579973/development-pipeline-biotech-companies-germany-therapy-fields/
